Kailera Therapeutics, Inc. Common Stock (KLRA · NASDAQ)
KLRA · MARKET VIEW
Market view · as of Sep 7, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-1.09
vs $-0.74 est · miss
52-wk position
7.8%
-37.6% vs 52w high · -13.0% 1mo
Price (last ~year)
Shares of clinical-stage biotechnology firm Kailera Therapeutics (KLRA) recently traded at $16.23, down 15.2% over the last three months, despite new institutional investments from Atlas Venture and Wellington Management disclosed in the second quarter. The company, which has a $2.10 billion market capitalization and no revenue to date, reported a net loss of $111.3 million for the quarter ending June 30, 2026. It currently holds $130.3 million in cash against $10.2 million in debt.
Valuation
- Market cap
- $2.10B
- P/B
- 1.825
- Analyst target
- $42.4
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -36.9%
- ROA
- -22.7%
Price movement
- Last
- $16.23
- 1-month
- -13.0%
- 3-month
- -15.2%
- RSI (14)
- 39
- vs SMA200
- -19.8%
- 52-wk position
- 7.8% -37.6% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $0 | $-121.4M | $-111.3M | $-111.3M |
| 2026-03-31 | $0 | $-84.7M | $-78.9M | $-84.6M |
| 2025-06-30 | $0 | $-30.7M | $-28.9M | $0 |
| 2025-03-31 | $0 | $-20.5M | $-18.0M | $0 |
Recent news
- Somewhat-Bullish Atlas Venture Life Science Advisors LLC Makes New Investment in Kailera Therapeutics, Inc. $KLRA · 2026-09-04
- Neutral 2,919,110 Shares in Kailera Therapeutics, Inc. $KLRA Acquired by Wellington Management Group LLP · 2026-09-03
- Somewhat-Bullish Kailera Therapeutics (NASDAQ:KLRA) Trading Up 7.9% - Here's Why · 2026-09-01
- Bearish Kailera Therapeutics (NASDAQ:KLRA) Reaches New 1-Year Low - Should You Sell? · 2026-08-31
- Bearish Kailera Therapeutics (NASDAQ:KLRA) Trading Down 8.6% - Should You Sell? · 2026-08-28
- Bearish Kailera Therapeutics (NASDAQ:KLRA) Hits New 1-Year Low - Here's Why · 2026-08-24
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)